US stocks closed mixed on Thursday as investors mulled weekly unemployment claims, rebounding oil prices, and a bleak report on a potential coronavirus vaccine. Jobless claims hit 4.4 million in the week ended April 18, declining from previous periods but pushing the metric’s five-week total above 26 million. WTI crude […]
Gilead stock plunged as much as 9% on Thursday after STAT News reported its experimental coronavirus drug remdesivir failed to improve patient conditions in a clinical trial. A summary of the trial’s results was mistakenly uploaded to the WHO’s website, STAT reported. The report contained “inappropriate characterizations of the study,” […]
Arcus Biosciences spiked as much as 99% in Thursday’s session after Bloomberg reported Gilead is in talks to invest in the company. Gilead is likely interested in Arcus’ AB154 therapy, a type of anti-TIGIT medicine that uses the immune system to fight tumours, analysts at Cantor Fitzgerald wrote in a […]
Gilead’s experimental coronavirus treatment has a 50/50 chance at gaining approval at best, RBC Capital Markets analysts wrote Wednesday. The biotech company soared amid the late February downturn after a World Health Organisation official deemed its remdesivir compound the best bet yet to combat the epidemic. Though the drug’s success […]
Gilead,Moderna, and Novavax have all enjoyed massive gains after announcing potential coronavirus drugs, leading their executives, scientists, and early investors to rake in millions. The profits come as global markets tank on growing coronavirus concerns. Moderna has gained the most of the three since Friday’s close, jumping 60% after announcing […]
Biotech company Gilead soared as much as 6.9% Monday morning after a World Health Organisation official made a hopeful comment on its experimental coronavirus treatment. The drug developer’s remdesivir compound is the “one drug right now that we think may have efficacy,” Bruce Aylward, an assistant director-general at the WHO, […]